How much funding does Cardiovascular Grant provide?

Cardiovascular Grant provides Approximately US $400,000 in funding.

When is the deadline for Cardiovascular Grant?

The funder has not published a deadline for this grant.

Who is eligible for Cardiovascular Grant?

Required: 501(c)(3) tax-exempt status.

Cardiovascular Grant

State of New Jersey Department of Health

State Grants for Nonprofits Healthcare Grants Community Health Grants Grants for Heart Disease

Funding Amount

Approximately US $400,000

Deadline

Deadline not published

Grant Type

State

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Eligible organizations

Municipal Government County Government State Government.

Required status

501(c)(3) tax-exempt status

Overview

The New Jersey Department of Health is offering a grant for evidence-based strategies aimed at preventing and managing cardiovascular disease in high-burden adult populations in Newark. The initiative seeks to enhance health outcomes by reducing hypertension rates through collaborative efforts among public health services and community organizations. Eligible applicants include municipal, county, and state governments, as well as non-profit organizations and health centers. This grant is pivotal in fostering healthier communities in New Jersey.

The scope of work for the public health system is ever-expanding, and the Department is on the frontlines in leading the response to public health challenges.
The Department has three primary branches – Public Health Services, Health Systems, and Integrated Health. All work collaboratively toward improving health by strengthening New Jersey’s health system.
Cardiovascular Disease Prevention Program
The New Jersey Department of Health (NJDOH) - Cardiovascular Disease Prevention Program (CVD) seeks to fund evidence-based strategies to prevent and manage cardiovascular disease in adult, high-burden populations/communities in Newark, contributing to improved health outcomes (reduction of hypertension rates in census tracts of focus), through population-based, evidence-based system interventions.